ICF appoints Dr. Michelle A. Williams to board, effective Dec 1, 2021

ICF International, Inc.

Board expanded from 8 to 9 members; Dr. Williams appointed as Class II director until 2023 annual meeting.
Dr. Williams designated to serve on the Audit Committee.
She is Dean of Harvard T.H. Chan School of Public Health and a renowned epidemiologist.
No material arrangements or related-party transactions in connection with her appointment.
Dr. Williams will receive standard non-employee director compensation package.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Michelle Williams

Class II Director

ICFI · ICF International, Inc.

Effective: 2021-12-01
Filed: November 9, 2021, 6:59 PM ET

Effective December 1, 2021, Dr. Williams shall be a Class II director, serving until the Company’s annual meeting of stockholders in 2023, subject to her prior death, resignation or removal from office as provided by law.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Michelle Williams was appointed as Class II Director at ICF International, Inc..

Action: appointed
Role: Class II Director

Exact text from the filing

Effective December 1, 2021, Dr. Williams shall be a Class II director, serving until the Company’s annual meeting of stockholders in 2023, subject to her prior death, resignation or removal from office as provided by law.

View on SEC.gov

ICF International, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-21-025924

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.